Matthew Cavender

15PUBLICATIONS

39CO-AUTHORS

Cardiology (incl. cardiovascular diseases)PharmacogenomicsRespiratory diseasesMolecular targetsEpidemiological modelling

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (15)

Sort by Publication Date:

|Jul 03, 2026

Importance of Hypercortisolism in BP Control, Cardiovascular Risk and in Patients With Difficult-to-Control Hypertension: An Overview for Primary Care Physicians.

|Mar 31, 2025

Oral Semaglutide and Cardiovascular Outcomes in High-Risk Type 2 Diabetes.

Darren K McGuire, Nikolaus Marx, Sharon L Mulvagh

|Feb 03, 2023

Epidemiology and Outcomes of Aortic Stenosis in Acute Decompensated Heart Failure: The ARIC Study.

Krishan Sivaraj, Sameer Arora, Michael Hendrickson

|Feb 08, 2022

Cardiovascular Effectiveness of Sodium-Glucose Cotransporter 2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists in Older Patients in Routine Clinical Care With or Without History of Atherosclerotic Cardiovascular Diseases or Heart Failure.

Phyo T Htoo, John Buse, Matthew Cavender

|Dec 17, 2021

Ischemic Events Occur Early in Patients Undergoing Percutaneous Coronary Intervention and Are Reduced With Cangrelor: Findings From CHAMPION PHOENIX.

Matthew A Cavender, Robert A Harrington, Gregg W Stone

|Feb 19, 2021

Association of sodium-glucose cotransporter-2 inhibitors with outcomes in type 2 diabetes with reduced and preserved left ventricular ejection fraction: Analysis from the CVD-REAL 2 study.

Carolyn S P Lam, Avraham Karasik, Cheli Melzer-Cohen

Pageof 3

Frequent Collaborators

Eric Wittbrodt

Carolyn S P Lam

Deepak L Bhatt

Colin P O'Leary

Karolina Andersson Sundell

Liyan Dong

Phillip Hunt

Nathan D Wong

Cheli Melzer-Cohen

Gregg W Stone

Frequent Collaborators

Eric Wittbrodt

Carolyn S P Lam

Deepak L Bhatt

Colin P O'Leary